نتایج جستجو برای: dystrophin related protein 2 gene drp2

تعداد نتایج: 4828568  

Journal: :Brain : a journal of neurology 2010
Matthew J A Wood Michael J Gait Haifang Yin

Splice-modulation therapy, whereby molecular manipulation of premessenger RNA splicing is engineered to yield genetic correction, is a promising novel therapy for genetic diseases of muscle and nerve-the prototypical example being Duchenne muscular dystrophy. Duchenne muscular dystrophy is the most common childhood genetic disease, affecting one in 3500 newborn boys, causing progressive muscle ...

Journal: :Frontiers in Cell and Developmental Biology 2023

Introduction: Delandistrogene moxeparvovec (SRP-9001) is an investigational gene transfer therapy designed for targeted expression of SRP-9001 dystrophin protein, a shortened retaining key functional domains the wild-type protein. Methods: This Phase 2, double-blind, two-part (48 weeks per part) crossover study (SRP-9001-102 [Study 102]; NCT03769116) evaluated delandistrogene in patients, aged ...

Journal: :Human molecular genetics 1996
D S Greenberg Y Schatz Z Levy P Pizzo D Yaffe U Nudel

Duchenne muscular dystrophy (DMD) is a progressive degenerative lethal muscle disease. A significant proportion of DMD affected children suffer also from mental retardation. The rod shaped protein, dystrophin, which is absent from or defective in the muscle of DMD patients, binds to a number of membrane associated proteins (known collectively as dystrophin associated proteins [DAPs]). The level...

2016
Martin Winterholler Christian Holländer Frank Kerling Irina Weber Sven Dittrich Matthias Türk Rolf Schröder

Duchenne muscular dystrophy (DMD) is the most frequent muscular dystrophy with an incidence of 1 in 3600 to 6000 male births. The disease usually manifests between the third and fifth year of life and leads to a steady decline in strength and motor function, contractures, and loss of ambulation between 9 and 13 years of age. Furthermore, the lack of dystrophin protein expression in cardiac tiss...

Journal: :Current Biology 2000
SarahE. Newey Matthew A. Benson Chris P. Ponting Kay E. Davies Derek J. Blake

Dystrophin coordinates the assembly of a complex of structural and signalling proteins that is required for normal muscle function. A key component of the dystrophin-associated protein complex (DPC) is alpha-dystrobrevin, a dystrophin-related and -associated protein whose absence results in muscular dystrophy and neuromuscular junction defects [1,2]. The current model of the DPC predicts that d...

Journal: :Arquivos De Neuro-psiquiatria 2023

Background: Duchenne muscular dystrophy (DMD) is caused by a mutation in the dystrophin gene and most common form of childhood-onset affecting approximately 1 3500 newborn boys. The disease invariably progressive patients with DMD exhibit signs muscle weakness before 5 years age. Loss ability to walk usually occurs between 10 13 years. Despite all advances management treatment over last decades...

2016
Merryl Rodrigues Yusuke Echigoya Rika Maruyama Kenji Rowel Q. Lim So-ichiro Fukada Toshifumi Yokota

Duchenne muscular dystrophy, one of the most common lethal genetic disorders, is caused by mutations in the DMD gene and a lack of dystrophin protein. In most DMD patients and animal models, sporadic dystrophin-positive muscle fibres, called revertant fibres (RFs), are observed in otherwise dystrophin-negative backgrounds. RFs are thought to arise from skeletal muscle precursor cells and clonal...

2013
Gail D. Thomas

Duchenne and Becker muscular dystrophy (DMD/BMD) comprise a spectrum of devastating X-linked muscle wasting disease for which there is no treatment. DMD/BMD is caused by mutations in the gene encoding dystrophin, a cytoskeletal protein that stabilizes the muscle membrane and also targets other proteins to the sarcolemma. Among these is the muscle-specific isoform of neuronal nitric oxide syntha...

Journal: :The European respiratory journal 1998
B J Petrof

The protein dystrophin is absent in the muscles of patients with Duchenne muscular dystrophy (DMD) as well as dystrophin-deficient mice with muscular dystrophy (mdx mice). The mdx mouse diaphragm closely resembles the human DMD phenotype and thus provides a useful model for studies of dystrophin gene replacement. Recombinant adenovirus vectors (AdVs) hold promise as a means for delivering a fun...

Journal: :Brain : a journal of neurology 2011
Karen Anthony Sebahattin Cirak Silvia Torelli Giorgio Tasca Lucy Feng Virginia Arechavala-Gomeza Annarita Armaroli Michela Guglieri Chiara S Straathof Jan J Verschuuren Annemieke Aartsma-Rus Paula Helderman-van den Enden Katherine Bushby Volker Straub Caroline Sewry Alessandra Ferlini Enzo Ricci Jennifer E Morgan Francesco Muntoni

Duchenne muscular dystrophy is caused by mutations in the DMD gene that disrupt the open reading frame and prevent the full translation of its protein product, dystrophin. Restoration of the open reading frame and dystrophin production can be achieved by exon skipping using antisense oligonucleotides targeted to splicing elements. This approach aims to transform the Duchenne muscular dystrophy ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید